What is Biological E, the Indian company producing Corbevax?

The Hyderabad-based company says the vaccine will provide sustainable access to low- and middle-income countries'

The Indian biotechnology and biopharmaceutical company Biological E has produced the country's first locally developed Covid-19 vaccine in partnership with the Texas Children's Hospital Center for Vaccine Development at Baylor College of Medicine.

The Hyderabad-based company has already produced 150m doses of the vaccine, called Corbevax, and will produce 100m doses each month beginning in February. It is expected that 1bn doses will be produced by the end of 2022 - just shy of India's nearly 1.4-billion population.